Favorable safety and immunogenicity of a combined quadrivalent influenza and recombinant SARS-CoV-2 vaccine in Sprague-Dawley rats for both primary and booster immunization - Top-Institutions - MDSpire

Safety and Immunogenic Response of a Novel Combined Quadrivalent Influenza and Recombinant SARS-CoV-2 Vaccine in Sprague-Dawley Rats During Primary and Booster Doses

  • By

  • Jinjin Shao

  • Chengda Zhang

  • Guangbiao She

  • Tian Qin

  • Jinyao Zhang

  • Minxi Fang

  • Dan Zhao

  • Linying Wang

  • Lijuan Xia

  • Qian Yang

  • Lili Zhang

  • Yanling Zhang

  • Siming Zhang

  • Jiahong Wang

  • Zhiqi Xie

  • Yunxiang Chen

  • Ying Chen

  • Enqi Huang

  • Lijiang Zhang

  • July 17, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Dale and Betty Bumpers Vaccine Research Center (VRC), NIAID, NIH
    Dale and Betty Bumpers Vaccine Research Center (VRC), NIAID, NIH

    Bethesda, Maryland

    Key Differentiators

    • Vaccine Research
    • Immunology

  • #2

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Vaccine Research
    • Influenza Pathogenesis

Original Source(s)

Favorable safety and immunogenicity of a combined quadrivalent influenza and recombinant SARS-CoV-2 vaccine in Sprague-Dawley rats for both primary and booster immunization

  • by Jinjin Shao, Chengda Zhang, Guangbiao She, Tian Qin, Jinyao Zhang, Minxi Fang, Dan Zhao, Linying Wang, Lijuan Xia, Qian Yang, Lili Zhang, Yanling Zhang, Siming Zhang, Jiahong Wang, Zhiqi Xie, Yunxiang Chen, Ying Chen, Enqi Huang, Lijiang Zhang

  • July 17, 2026

Related Content

Differentiated associations of inflammatory indices with laboratory-defined organ injury/involvement and hospitalization length in pediatric respiratory tract infections

Improving fidelity of implementation of self-administered pulse oximetry and remote patient monitoring in Honduras during the COVID-19 pandemic

Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2